Davis Polk partner Alan Denenberg joined CNBC’s “Power Lunch” to discuss the growing backlog of IPO filings at the SEC and how the government shutdown will impact companies – particularly those in the biotech space – that were planning to file an IPO in 2019.

“This was supposed to be a big year for IPOs, but the government shutdown could ruin it” CNBC (January 9, 2019)

Copy link to share post